Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge

Molecular and Cellular Proteomics

Volumn 4, Issue 9, 2005, Pages 1251-1264

  Wu, Jiang ^a   Kobayashi, Michiko ^b   Sousa, Eric A ^a   Liu, Wei ^a   Cai, Jie ^b   Goldman, Samuel J ^b   Dorner, Andrew J ^a   Projan, Steven J ^b   Kavuru, Mani S ^c   Qiu, Yongchang ^a   Thomassen, Mary Jane ^c  

^a PFIZER INC   (United States)

^b The Inflammation Research Foundation   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALLERGEN; BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; MATRIX PROTEIN; PROTEIN; PROTEINASE;

ADULT; ALLERGIC ASTHMA; ARTICLE; CASE REPORT; COMPLEMENT FACTOR; CONTROLLED STUDY; DATA BASE; EOSINOPHILIA; FEMALE; HUMAN; INFLAMMATION; LIQUID CHROMATOGRAPHY; LUNG LAVAGE; MALE; MASS SPECTROMETRY; MUCUS; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; PROVOCATION TEST; TISSUE INJURY; TISSUE REPAIR;

EID: 26844454132     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M500041-MCP200     Document Type: Article

References (57)

1. Cohn, L., Elias, J. A., and Chupp, G. L. (2004) Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22, 789-815
2. Fehniger, T. E., Sato-Folatre, J. G., Malmstrom, J., Berglund, M., Lindberg, C., Brange, C., Lindberg, H., and Marko-Varga, G. (2004) Exploring the context of the lung proteome within the airway mucosa following allergen challenge. J. Proteome. Res. 3, 307-320
3. Hamid, Q., Tulic, M. K., Liu, M. C., and Moqbel, R. (2003) Inflammatory cells in asthma: mechanisms and implications for therapy. J. Allergy Clin. Immunol. 111, S5-S12
4. Persson, C. G., Andersson, M., Greiff, L., Svensson, C., Erjefalt, J. S., Sundler, F., Wollmer, P., Alkner, U., Erjefalt, I., and Gustafsson, B. (1995) Airway permeability. Clin. Exp. Allergy 25, 807-814
5. Pradalier, A. (1993) Late-phase reaction in asthma: basic mechanisms. Int. Arch. Allergy Immunol. 101, 322-325
6. Kavuru, M. S., Dweik, R. A., and Thomassen, M. J. (1999) Role of bronchoscopy in asthma research. Clin. Chest Med. 20, 153-189
7. Bowler, R. P., Duda, B., Chan, E. D., Enghild, J. J., Ware, L. B., Matthay, M. A., and Duncan, M. W. (2004) Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am. J. Physiol. 286, L1095-L1104
8. Nocker, R. E., van der Zee, J. S., Weller, F. R., van Overveld, F. J., Jansen, H. M., and Out, T. A. (1999) Segmental allergen challenge induces plasma protein leakage into the airways of asthmatic subjects at 4 hours but not at 5 minutes after challenge. J. Lab. Clin. Med. 134, 74-82
9. Plymoth, A., Lofdahl, C. G., Ekberg-Jansson, A., Dahlback, M., Lindberg, H., Fehniger, T. E., and Marko-Varga, G. (2003) Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation. Proteomics 3, 962-972
10. Rennard, S. I., Basset, G., Lecossier, D., O'Donnell, K. M., Pinkston, P., Martin, P. G., and Crystal, R. G. (1986) Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60, 532-538
11. Noel-Georis, I., Bernard, A., Falmagne, P., and Wattiez, R. (2002) Database of bronchoalveolar lavage fluid proteins. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 771, 221-236
12. Washburn, M. P., Wolters, D., and Yates, J. R., III (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242-247
13. Link, A. J., Eng, J., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., and Yates, J. R., III (1999) Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 17, 676-682
14. Adkins, J. N., Varnum, S. M., Auberry, K. J., Moore, R. J., Angell, N. H., Smith, R. D., Springer, D. L., and Pounds, J. G. (2002) Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteomics 1, 947-955
15. Pang, J. X., Ginanni, N., Dongre, A. R., Hefta, S. A., and Opitek, G. J. (2002) Biomarker discovery in urine by proteomics. J. Proteome Res. 1, 161-169
16. Liao, H., Wu, J., Kuhn, E., Chin, W., Chang, B., Jones, M. D., O'Neil, S., Clauser, K. R., Karl, J., Hasler, F., Roubenoff, R., Zolg, W., and Guild, B. C. (2004) Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum. 50, 3792-3803
17. Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D., Adkins, J. N., Pounds, J. G., Fagan, R., and Lobley, A. (2004) The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 3, 311-326
18. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999
19. Chelius, D., Zhang, T., Wang, G., and Shen, R. F. (2003) Global protein identification and quantification technology using two-dimensional liquid chromatography nanospray mass spectrometry. Anal. Chem. 75, 6658-6665
20. Bondarenko, P. V., Chelius, D., and Shaler, T. A. (2002) Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal. Chem. 74, 4741-4749
21. Wang, W., Zhou, H., Lin, H., Roy, S., Shaler, T. A., Hill, L. R., Norton, S., Kumar, P., Anderle, M., and Becker, C. H. (2003) Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem. 75, 4818-4826
22. Drynda, S., Ringel, B., Kekow, M., Kuhne, C., Drynda, A., Glocker, M. O., Thiesen, H. J., and Kekow, J. (2004) Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFα therapy. Pathol. Res. Pract. 200, 165-171
23. Wattiez, R., Hermans, C., Cruyt, C., Bernard, A., and Falmagne, P. (2000) Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis 21, 2703-2712
24. Wattiez, R., Hermans, C., Bernard, A., Lesur, O., and Falmagne, P. (1999) Human bronchoalveolar lavage fluid: two-dimensional gel electrophoresis, amino acid microsequencing and identification of major proteins. Electrophoresis 20, 1634-1645
25. Wang, J. Y., Shieh, C. C., Yu, C. K., and Lei, H. Y. (2001) Allergen-induced bronchial inflammation is associated with decreased levels of surfactant proteins A and D in a murine model of asthma. Clin. Exp. Allergy 31, 652-662
26. Sabounchi-Schutt, F., Astrom, J., Hellman, U., Eklund, A., and Grunewald, J. (2003) Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach. Eur. Respir. J. 21, 414-420
27. Noel-Georis, I., Bernard, A., Falmagne, P., and Wattiez, R. (2001) Proteomics as the tool to search for lung disease markers in bronchoalveolar lavage. Dis. Markers 17, 271-284
28. Malmstrom, J., Larsen, K., Malmstrom, L., Tufvesson, E., Parker, K., Marchese, J., Williamson, B., Hattan, S., Patterson, D., Martin, S., Graber, A., Juhasz, H. P., Westergren-Thorsson, G., and Marko-Varga, G. (2004) Proteome annotations and identifications of the human pulmonary fibroblast. J. Proteome Res. 3, 525-537
29. Houtman, R., Krijgsveld, J., Kool, M., Romijn, E. P., Redegeld, F. A., Nijkamp, F. P., Heck, A. J., and Humphery-Smith, I. (2003) Lung proteome alterations in a mouse model for nonallergic asthma. Proteomics 3, 2008-2018
30. Hirsch, J., Hansen, K. C., Burlingame, A. L., and Matthay, M. A. (2004) Proteomics: current techniques and potential applications to lung disease. Am. J. Physiol. 287, L1-L23
31. Griese, M., von Bredow, C., and Birrer, P. (2001) Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled α1-protease inhibitor in cystic fibrosis. Electrophoresis 22, 165-171
32. Houtman, R., and van den Worm, E. (2005) Asthma, the ugly duckling of lung disease proteomics? J. Chromatogr. B 815, 285-294
33. Wattiez, R., and Falmagne, P. (2005) Proteomics of bronchoalveolar lavage fluid. J. Chromatogr. B 815, 169-178
34. National Heart, Lung, and Blood Institute (1997) Expert Panel Report 2, Guidelines for the Diagnosis and Management of Asthma, Publication 97-4051, National Institutes of Health, Bethesda, MD
35. Chai, H., Farr, R. S., Froehlich, L. A., Mathison, D. A., McLean, J. A., Rosenthal, R. R., Sheffer, A. L., Spector, S. L., and Townley, R. G. (1975) Standardization of bronchial inhalation challenge procedures. J. Allergy Clin. Immunol. 56, 323-327
36. Thomassen, M. J., Buhrow, L. T., Connors, M. J., Kaneko, F. T., Erzurum, S. C., and Kavuru, M. S. (1997) Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 17, 279-283
37. Ashburner, M., Ball, O. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G. M., and Sherlock, G. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29
38. Gerke, V., and Moss, S. E. (2002) Annexins: from structure to function. Physiol. Rev. 82, 331-371
39. Perretti, M. (1998) Lipocortin 1 and chemokine modulation of granulocyte and monocyte accumulation in experimental inflammation. Gen. Pharmacol. 31, 545-552
40. Degryse, B., Bonaldi, T., Scaffidi, P., Muller, S., Resnati, M., Sanvito, F., Arrigoni, G., and Bianchi, M. E. (2001) The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152, 1197-1206
41. Erlandsson Harris, H., and Andersson, U. (2004) Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 34, 1503-1512
42. Czura, C. J., Yang, H., Amella, C. A., and Tracey, K. J. (2004) HMGB1 in the immunology of sepsis (not septic shock) and arthritis. Adv. Immunol. 84, 181-200
43. Sama, A. E., D'Amore, J., Ward, M. F., Chen, G., and Wang, H. (2004) Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department. Acad. Emerg. Med. 11, 867-873
44. Lampinen, M., Carlson, M., Hakansson, L. D., and Venge, P. (2004) Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59, 793-805
45. Liu, L., Jarjour, N. N., Busse, W. W., and Kelly, E. A. (2004) Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. Am. J. Respir. Crit. Care Med. 169, 1118-1124
46. Vermaelen, K. Y., Cataldo, D., Tournoy, K., Maes, T., Dhulst, A., Louis, R., Foidart, J. M., Noel, A., and Pauwels, R. (2003) Matrix metalloproteinase-9-mediated dendritic cell recruitment into the airways is a critical step in a mouse model of asthma. J. Immunol. 171, 1016-1022
47. Takafuji, S., Ishida, A., Miyakuni, Y., and Nakagawa, T. (2003) Matrix metalloproteinase-9 release from human leukocytes. J. Investig. Allergol. Clin. Immunol. 13, 50-55
48. Suzuki, R., Miyazaki, Y., Takagi, K., Torii, K., and Taniguchi, H. (2004) Matrix metalloproteinases in the pathogenesis of asthma and COPD: implications for therapy. Treat. Respir. Med. 3, 17-27
49. Parks, W. C., and Shapiro, S. D. (2001) Matrix metalloproteinases in lung biology. Respir. Res. 2, 10-19
50. Maisi, P., Sorsa, T., Raulo, S. M., Prikk, K., Sepper, R., and McGorum, B. (2001) Increased matrix metalloproteinase (MMP)-9 in the airway after allergen challenge. Am. J. Respir. Crit. Care Med. 164, 1740
51. Bingle, C. D., and Gorr, S. U. (2004) Host defense in oral and airway epithelia: chromosome 20 contributes a new protein family. Int. J. Biochem. Cell Biol. 36, 2144-2152
52. Brass, D. M., Savov, J. D., Whitehead, G. S., Maxwell, A. B., and Schwartz, D. A. (2004) LPS binding protein is important in the airway response to inhaled endotoxin. J. Allergy Clin. Immunol. 114, 586-592
53. Fujita, T., Matsushita, M., and Endo, Y. (2004) The lectin-complement pathway - its role in innate immunity and evolution. Immunol. Rev. 198, 185-202
54. Tsuji, S., Uehori, J., Matsumoto, M., Suzuki, Y., Matsuhisa, A., Toyoshima, K., and Seya, T. (2001) Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J. Biol. Chem. 276, 23456-23463
55. Hoshino, M., Nakamura, Y., Sim, J. J., Yamashiro, Y., Uchida, K., Hosaka, K., and Isogai, S. (1998) Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin. Exp. Allergy 28, 568-577
56. Danilkovitch-Miagkova, A., and Leonard, E. J. (2001) Anti-apoptotic action of macrophage stimulating protein (MSP). Apoptosis 6, 183-190
57. Wang, M. H., Zhou, Y. Q., and Chen, Y. Q. (2002) Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities. Scand. J. Immunol. 56, 545-553